Eatris

Eatris EATRIS is an European Infrastructure for translational medicine and a non-profit European Research Infrastructure Consortium (ERIC).

đź“Ł Following an EATRIS-CONNECT event on ageing hosted by the School of Medicine University of Zagreb, connections formed ...
04/09/2026

📣 Following an EATRIS-CONNECT event on ageing hosted by the School of Medicine University of Zagreb, connections formed between EATRIS, SHARE-ERIC and academic partners have developed into ONCOLIGHT – Systems Learning for Equitable Cancer Care.

Funded through Erasmus+, the three-year project will bring together partners from Croatia, the Netherlands, Spain and TĂĽrkiye to develop an interdisciplinary educational programme addressing the complexity of modern cancer care.

The project shows how collaboration between research infrastructures can spark new partnerships and create impact beyond research.

👉 Read more here: https://eatris.eu/news/fostering-innovation-through-cross-ri-collaboration-how-an-eatris-connect-event-helped-spark-the-oncolight-project/

đź’Š Join the REMEDi4ALL Patient Bootcamp in Barcelona on 10-11 June 2027 to take the next step in advancing your expertise...
04/09/2026

đź’Š Join the REMEDi4ALL Patient Bootcamp in Barcelona on 10-11 June 2027 to take the next step in advancing your expertise in the field of !

Through expert-led sessions, real-world case studies and interactive discussions, participants will also explore regulatory pathways, clinical trials and effective patient engagement.

👉 Find out more and apply here: https://remedi4all.org/repurposing-bootcamp-for-patient-representatives-2027/

⏰ One week left to express interest in the Erdera Clinical Trial Call (ECTC) to support multinational, GCP‑compliant ear...
03/09/2026

⏰ One week left to express interest in the Erdera Clinical Trial Call (ECTC) to support multinational, GCP‑compliant early‑phase interventional clinical trials in rare diseases.

The call will fund studies designed to generate robust clinical evidence, strengthen regulatory readiness and make rare disease trials more feasible across countries.

đź“… Deadline to express interest: 10 September

👉 Learn more and apply here: https://erdera.org/call/ctc2026/

03/09/2026

Did you know that people can already apply to access data from the EUCAIM platform for their research projects?

In a recent video, experts from EUCAIM, including Sara Zullino (EATRIS Scientific Lead AI for Medical Applications), share the latest updates on the project!

👉 Learn more about EUCAIM and EATRIS' role in the project here: https://eatris.eu/projects/eucaim-european-federation-for-cancer-images/

Join the upcoming Erdera webinar, Public-Private Collaboration Accelerator – How to Pitch to Investors, for practical gu...
02/09/2026

Join the upcoming Erdera webinar, Public-Private Collaboration Accelerator – How to Pitch to Investors, for practical guidance on presenting early-stage projects to potential funders on 6 September 2026.

An academic researcher and Venture Builder will share insights from three years of collaboration, followed by a roundtable exploring what venture capital investors look for when assessing early-stage projects.

The webinar is aimed at researchers, clinicians, academics and SMEs working to advance rare disease therapies, targets and other translational innovations.

👉 Learn more and register here: https://eatris.eu/events/how-to-pitch-to-investors/

The European Medicines Agency (EMA) has begun a phased review of daraxonrasib, an investigational medicine for metastati...
02/09/2026

The European Medicines Agency (EMA) has begun a phased review of daraxonrasib, an investigational medicine for metastatic .

Daraxonrasib has been designated a high priority under EMA’s Cancer Medicines Pathfinder because of its potential to address a significant unmet medical need for patients whose disease has progressed after previous treatment. The approach could accelerate its assessment while maintaining the same standards for quality, safety and efficacy.

👉 Read more here: https://www.ema.europa.eu/en/news/ema-fast-tracks-review-medicine-metastatic-pancreatic-cancer

Following the establishment of 17 National Cancer Mission Hubs, ECHoS is entering its second phase, bringing together 61...
01/09/2026

Following the establishment of 17 National Cancer Mission Hubs, ECHoS is entering its second phase, bringing together 61 organisations across 30 countries to strengthen collaboration and advance the EU Mission on Cancer.

Through EU-AMRI, EATRIS, BBMRI ERIC and ECRIN-ERIC will connect the Hubs with relevant expertise, infrastructure and services to help translate European priorities into action within national research and health systems.

As EATRIS Scientific Director Toni Andreu explains: “Delivering the Cancer Mission requires more than strategic alignment; it requires the capacity to translate European ambitions into action.”

👉 Read the press release and learn more about the next phase of ECHoS: http://eatris.eu/news/europe-charts-an-ambitious-roadmap-for-the-next-five-years-as-a-european-network-of-national-cancer-mission-hubs-takes-shape

📢 Abstract submissions are open for CTGCT Day 2026: Advances in Cell, Tissue and Gene Therapy.Taking place on 11 Novembe...
01/09/2026

📢 Abstract submissions are open for CTGCT Day 2026: Advances in Cell, Tissue and Gene Therapy.

Taking place on 11 November in Ljubljana, the conference will bring together researchers, clinicians, biotechnology professionals and regulatory experts to discuss advances in gene and cell therapy, emerging ATMPs, manufacturing and translation, and regulatory and ethical considerations.

Researchers are invited to submit abstracts for oral or poster presentations by 15 September. Attendance is free, but places are limited.

👉 Learn more and register here before 31 October: https://eatris.eu/events/ctgct-day-2026-advances-in-cell-tissue-and-gene-therapy/

đź“ť Join the European Federation for Cancer Images (EUCAIM) at ECR 2027 and submit an abstract for EIBIR Booth Sessions! T...
31/08/2026

đź“ť Join the European Federation for Cancer Images (EUCAIM) at ECR 2027 and submit an abstract for EIBIR Booth Sessions!

The European Institute for Biomedical Imaging Research(EIBIR) invites researchers to submit poster abstracts for the EIBIR Booth Sessions, where selected authors will have the chance to present their work through a short oral presentation at the EIBIR booth during the congress.

Topics include:
🔹AI in Radiology (oncologic, cardiovascular and neuro-imaging)
🔹Emerging technologies
🔹Hybrid imaging in oncology and cardiovascular disease
🔹Integrated diagnostics
🔹Multidisciplinary research and collaboration

EUCAIM will have its own session at the ECR, so this could also be a great opportunity for you to ask your questions!

⌛ Submission period: 3 August – 30 September 2026
đź”— Submit your abstract here: https://www.myesr.org/congress/submit/abstract-submission/

đź“Ł The 2026 registration deadline has been extended to 18 September, giving EATRIS members more time to take advantage ...
31/08/2026

đź“Ł The 2026 registration deadline has been extended to 18 September, giving EATRIS members more time to take advantage of a special offer.

EATRIS members can register for €350 instead of €550. We have also pre-booked one on-site room per EATRIS member state, available at the exceptional rate of €200 for four nights.

TMex brings together researchers and professionals from across Europe for an immersive introduction to the principles and practice of translational medicine.

👉 Learn more about TMex and register here: https://eatris.eu/events/translational-medicine-explored-tmex-2026/

Adres

De Boelelaan 1117
Amsterdam
1081HV

Telefoon

+31204442254

Website

Meldingen

Wees de eerste die het weet en laat ons u een e-mail sturen wanneer Eatris nieuws en promoties plaatst. Uw e-mailadres wordt niet voor andere doeleinden gebruikt en u kunt zich op elk gewenst moment afmelden.

Contact De Organisatie

Stuur een bericht naar Eatris:

Snelkoppelingen

Uitgelicht

Delen

Type